Skip to main content

Table 1 Antimicrobial susceptibility against carbapenemase-producing Enterobacterales

From: Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador

Antimicrobials

CPE (n = 60)

K. pneumoniae blaKPC (n = 40)

K. pneumoniae blaNDM (n = 5)

Klebsiella aerogenes blaKPC (n = 9)

Susceptible

Susceptible

MIC50 µg/ml

MIC90 µg/ml

Susceptible

MIC50 µg/ml

MIC90 µg/ml

Susceptible

MIC50 µg/ml

MIC90 µg/ml

No

%

No

%

No

%

No

%

AK

27

45.00

21

47.73

4

 ≥ 64

0

0.00

 ≥ 64

 ≥ 64

2

22.22

 ≥ 64

 ≥ 64

GN

11

18.33

8

18.18

 ≥ 64

 ≥ 64

0

0.00

 ≥ 64

 ≥ 64

2

22.22

 ≥ 64

 ≥ 64

CIP

8

13.33

5

11.36

 ≥ 4

 ≥ 4

1

20.00

 ≥ 4

 ≥ 4

2

22.22

 ≥ 4

 ≥ 4

SXT

4

6.67

4

9.09

4/76

4/76

0

0.00

4/76

4/76

0

0.00

4/76

4/76

TIG

57

95.00

38

86.36

 ≤ 0,5

 ≤ 0,5

5

100.00

2

2

9

100.00

 ≤ 0.5

 ≤ 0.5

COL

46

76.67

34

85.00

1

 ≥ 8

5

100.00

1

1

1

11.11

 ≥ 8

 ≥ 8

CAZ/AVI

53a

100.00

40

100.00

 ≤ 0.12/4

 ≤ 0.12/4

NT

NT

NT

NT

9

100.00

DD

DD

MER/VAB

25b

100.00

23c

100.00

0.064/8

0.94/8

NT

NT

NT

NT

1d

100.00

-

-

CAZ

0

0.00

0

0.00

 ≥ 64

 ≥ 64

0

0

 ≥ 64

 ≥ 64

0

0.00

 ≥ 64

 ≥ 64

FEP

1

0.00

0

0.00

 ≥ 32

 ≥ 32

0

0

 ≥ 32

 ≥ 32

0

0.00

 ≥ 32

 ≥ 32

IMP

1

3.33

0

0.00

 ≥ 16

 ≥ 16

0

0

 ≥ 16

 ≥ 16

0

0.00

 ≥ 16

 ≥ 16

MER

1

3.33

0

0.00

 ≥ 16

 ≥ 16

0

0

 ≥ 16

 ≥ 16

0

0.00

 ≥ 16

 ≥ 16

PTZ

0

0.00

0

0

 ≥ 128/4

 ≥ 128/4

0

0

 ≥ 128/4

 ≥ 128/4

0

0.00

 ≥ 128/4

 ≥ 128/4

  1. NT not tested, DD disk diffusion, AK Amikacin, GN Gentamicin, CIP Ciprofloxacin, SXT Trimethoprim/sulfamethoxazole, TIG Tigecycline, COL Colistin, CAZ/AVI Ceftazidime/Avibactam, MER/VAB Meropenem/vaborbactam, CAZ Ceftazidime, FEP Cefepime, IMP Imipenem, MER Meropenem, PTZ Piperacillin/tazobactam
  2. a53 isolates tested
  3. b25 isolates tested
  4. c23 isolates tested
  5. d1 isolate tested